首页|期刊导航|肿瘤预防与治疗|螺旋断层放疗中虚拟挡块技术对左侧乳腺癌保乳术后患者危及器官的保护效果:三种模式的剂量学比较

螺旋断层放疗中虚拟挡块技术对左侧乳腺癌保乳术后患者危及器官的保护效果:三种模式的剂量学比较OA

Dosimetric Comparison of Three Virtual Block Modalities in Helical To-motherapy and Their Protective Effects on Organs-at-Risk in Left-Sided Breast Cancer Patients after Breast-Conserving Surgery

中文摘要英文摘要

目的:探讨在左侧乳腺癌保乳术后螺旋断层放疗(helical tomotherapy,HT)计划中应用不同虚拟挡块(block)模式(Allowed、Exit Only 和Never)对降低危及器官(organs at risk,OARs)剂量的有效性及对治疗效率的影响.方法:回顾性分析 21 例接受放疗的左侧乳腺癌保乳术后患者资料.为每例患者分别设计 HT 的 Allowed 计划(HTa)、Exit Only 计划(HTe)和 Never 计划(HTn).比较各组计划靶区和 OARs 的剂量学参数、机器跳数及出束时间(beam-on time,BOT).结果:靶区剂量保护方面,三组计划均满足临床剂量要求.HTn 组的覆盖度 V100 和热点 V107在三组中最高(P<0.05),HTe 的适形度指数优于 HTa 和 HTn 组(P<0.05).三组计划均匀性指数的差异无统计学意义(P>0.05).OARs 保护方面,HTa 组除心脏 V20、V30 外,其它所有 OARs 均显著高于另外两组,差异有统计学意义(P<0.05).HTn 将对侧肺 V5、V10 中位数降至0%,显著低于 HTa 和 HTe 组(P<0.001).HTe 和 HTn 对侧肺 Dmean与 HTa 组相比降幅分别达到34.5%和91.4%(P<0.001).与HTa 相比,HTe 和HTn 组对侧乳腺Dmean 的降幅也分别达到 29.6%和 57.7%(P<0.001).两两比较显示,HTn 肝脏 Dmean 和脊髓 Dmax 明显低于 HTe 组(P≤0.001),HTe 同侧肺和心脏的 V5、V10 和 Dmean 与 HTn 组相比差异无统计学意义(P>0.05).然而,与 HTa 相比,HTn 和 HTe 组的BOT 分别增加了 179.2%和 39.1%(P<0.001).结论:HT 计划中应用 Allowed 模式的剂量学参数明显处于劣势.Exit Only 模式可在不影响靶区覆盖的前提下有效降低多器官的照射剂量,出束时间略有增加但仍属临床可接受范围.Never 模式可最大程度保护 OARs,尤其适用于对侧器官敏感或需极低剂量照射的患者,但 BOT 显著延长,效率最低.临床应用根据患者身体状况、治疗耐受性和个体化差异在 Exit Only 和 Never 中选择挡块模式.

Objective:To explore the effectiveness of ap-plying different virtual block modes(Allowed,Exit Only and Never)in reducing the dose of organs at risk(OARs)and the impact on treatment efficiency in helical tomotherapy(HT)planning after breast-conserving surgery for left breast cancer.Methods:Data from 21 postoperative patients with left-sided breast cancer who received radiotherapy after breast-conserving surgery were retrospectively analyzed.Three HT plans—Allowed(HTa),Exit Only(HTe),and Never(HTn)—were de-signed for each patient.The dosimetric parameters of the planning target volume and OARs,the monitor units,and the beam-on time(BOT)were compared among the three plans in each patient.Results:In terms of target dose coverage,all three plans met the clinical dose requirements.The coverage V100 and hot spot V107 of HTn were the highest among the three groups(P<0.05),and the conformity index of HTe was superior to HTa and HTn groups(P<0.05).There was no sig-nificant difference in the homogeneity index among the three groups(P>0.05).In terms of organs at risk(OARs)spar-ing,the HTa group demonstrated significantly higher doses/values for all OARs compared to the other two groups,with the exception of heart V20 and V30,and the differences were statistically significant(P<0.05).HTn reduced the median of V5 and V10 of the contralateral lung to 0%,which was significantly lower than that of HTa and HTe groups(P<0.001).The contralateral lung mean dose(Dmean)of the HTe and HTn compared with HTa group decreased by 34.5%and 91.4%,re-spectively(P<0.001).Compared with HTa,the contralateral breast Dmean in the HTe and HTn groups also decreased by 29.6%and 57.7%,respectively(P<0.001).Pairwise comparisons indicated that the liver Dmean and spinal cord Dmax in the HTn were significantly lower than those in the HTe group(P≤0.001),and compared with HTn,there were no signifi-cant differences in V5,V10,and Dmean of the ipsilateral lung and heart in the HTe group(P>0.05).However,compared with HTa,the BOT of the HTn and HTe increased by 179.2%and 39.1%,respectively(P<0.001).Conclusion:The dosimetric parameters of the Allowed mode in HT plans are significantly at a disadvantage.The application of Exit Only mode in the HT plan can effectively reduce the radiation dose of multiple organs without affecting the target area coverage,and the BOT is slightly increased but still within the clinically acceptable range.Never mode can protect OARs to the greatest extent,especially for patients with sensitive contralateral organs or who require extremely low-dose radiation,but the BOT is signifi-cantly prolonged with the lowest efficiency.For clinical application,the block mode(Exit Only or Never)should be selected based on the patient's physical condition,treatment tolerance,and individual differences.

刘旭红;夏耀雄;柏晗;陈飞虎;陈晓

650118 昆明,昆明医科大学第三附属医院,云南省肿瘤医院,北京大学肿瘤医院云南医院 放射治疗科650118 昆明,昆明医科大学第三附属医院,云南省肿瘤医院,北京大学肿瘤医院云南医院 放射治疗科650118 昆明,昆明医科大学第三附属医院,云南省肿瘤医院,北京大学肿瘤医院云南医院 放射治疗科650118 昆明,昆明医科大学第三附属医院,云南省肿瘤医院,北京大学肿瘤医院云南医院 放射治疗科650118 昆明,昆明医科大学第三附属医院,云南省肿瘤医院,北京大学肿瘤医院云南医院 放射治疗科

医药卫生

左侧乳腺癌保乳术后螺旋断层放射治疗低剂量区定向阻断完全阻断

After left-sided breast conserving surgeryHelical tomotherapyLow-dose volumeExit OnlyNever

《肿瘤预防与治疗》 2026 (8)

676-684,9

云南省级临床医学中心科研项目(编号:2024YNLCYXZX0403) This study was supported by grants from Health Commission of Yunnan Province(No.2024YNLCYXZX0403).

10.3969/j.issn.1674-0904.2026.08.007

评论